Cancer Newswire (Page 3)

Comprehensive Real-Time News Feed for Cancer. (Page 3)

Results 41 - 60 of 24,783 in Cancer

  1. What is value in cancer care? It depends.Read the original story w/Photo

    Friday | Kevin, M.D.

    A simple word with lots of meanings, all of which depend on the context of the moment. Value in health care - especially in cancer care - is certainly no exception.

    Comment?

  2. Bon Secours Cancer Institute at DePaul opensRead the original story w/Photo

    Friday Dec 19 | Hampton Roads Daily Press

    Kathy Brooks, dosimetrist and manager of the Bon Secours Cancer Institute at De Paul Medical Center, Norfolk. Brooks is demonstrating a mold and the tubes used for brachytherapy on a hand.

    Comment?

  3. Terminally ill boy gets custom-built hobbit houseRead the original story w/Photo

    Friday Dec 19 | WBAL-TV Baltimore

    Eight-year-old Rem Lomat, who suffers from terminal cancer, loves "The Hobbit," so the Make a Wish Foundation made his tiny dream a reality for the family. INVOLVED, SCHOOL WAS PUT ON LOCKDOWN.

    Comment?

  4. AstraZeneca's ovarian cancer drug, Lynparza, gets U.S. approvalRead the original story w/Photo

    Friday Dec 19 | Medical Daily

    AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission. An advisory panel to the U.S. Food and Drug Administration had voted in June against granting an accelerated approval to the drug, Lynparza, citing inadequate data.

    Comment?

  5. FDA Approves AstraZeneca Ovarian Cancer DrugRead the original story w/Photo

    Friday Dec 19 | Wall Street Journal

    In what regulators called the latest advance in the development of personalized medicine, the U.S. Food and Drug Administration on Friday approved the first drug to treat cases of ovarian cancer linked to specific genetic mutations. The drug, made by AstraZeneca PLC, was approved for women with defective genes, known as BRCA1 and BRCA2, who have advanced ovarian cancer.

    Comment?

  6. Prentice says decline in oil revenue means all capital projects now under reviewRead the original story w/Photo

    Friday Dec 19 | GlobalNews

    ... committee will examine all government capital projects says the premier and he has also confirmed a $1.3 billion cancer treatment centre planned for Calgary has been deferred. "The project is under review," said Prentice. "I would anticipate that it ...

    Comment?

  7. Juno Therapeutics Debuts on the Nasdaq, Stock Soars 50%Read the original story w/Photo

    Friday Dec 19 | TheStreet.com

    ... with shares initially expected to price between $15 and $18. CEO Hans Bishop says the company is focused on improving cancer treatments used on patients. Specifically, Juno Therapeutics is working on a process that "reprograms" the immune system, ...

    Comment?

  8. Cancer Treatment Costs Weigh Heavily on Patients, Study FindsRead the original story w/Photo

    Friday Dec 19 | MedicineNet

    Researchers examined data from 1,000 people in the United States who had been diagnosed with colorectal or lung cancer . Of those patients, almost 900 had finished their treatments and were cancer-free, and more than 100 had advanced cancer.

    Comment?

  9. 'Financial toxicity' can lower cancer patients' quality of lifeRead the original story w/Photo

    Tuesday Dec 16 | Science Daily

    Doctors who treat cancer are vigilant when it comes to the physical side effects of the therapies they prescribe, but financial stress from accumulating medical bills can also weigh on patients' health - even those who have finished their treatments and are cancer-free. Doctors who treat cancer are vigilant when it comes to the physical side effects of the therapies they prescribe, but financial stress from accumulating medical bills can also weigh on patients' health -- even those who have finished their treatments and are cancer-free.

    Comment?

  10. Vote to send Upstate lung cancer survivors to Super Bowl XLIXRead the original story w/Photo

    Tuesday Dec 16 | FOX Carolina

    "My wife Keasha grew up here in the Greenville area; she was diagnosed with lung cancer December 2010," Chris Draft said. Draft is a former NFL player, but lung cancer is one of the most difficult challengers he's ever had to tackle.

    Comment?

  11. Targeted treatment herceptin found to greatly improve long-term...Read the original story w/Photo

    Monday Dec 15 | Science Daily

    Clinical trials have demonstrated that trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients. The study found that Herceptin, when added to chemotherapy, improved 10-year survival from 75 percent with chemotherapy alone to 84 percent with the addition of trastuzumab.

    Comment?

  12. GOP leader announces hea ll undergo cancer treatmentRead the original story w/Photo

    Friday Dec 19 | WKRN

    Republican Caucus Chairman Bill Ketron of Murfreesboro told media on Thursday that he has been diagnosed with non-Hodgkin's lymphoma. He said in a statement that the cancer was found last month after he discovered a lump in his neck.

    Comment?

  13. The return of Fleetwood MacRead the original story w/Photo

    Friday Dec 19 | The Miami Herald

    ... Stop , with Fleetwood Mac at a London concert. After a hiatus for her ex-husband John McVie to seek treatment for cancer, the band announced its official reunion earlier this year. McVie's return reunites the classic Rumours -era lineup as she once ...

    Comment?

  14. C. R. Bard, Cook Medical and Boston Scientific Lead the U.S. Nephrostomy MarketRead the original story

    Friday Dec 19 | GlobeNewswire

    ... rise in percutaneous nephrostomy (PCN) procedures. Growth in procedures will be driven by the incidence of bladder cancer cases, genealogical malignancies and urinary calculi. In 2014 the American Cancer Society's estimates that there are 74,690 new ...

    Comment?

  15. Gilead strikes cancer drug deal as it moves into oncologyRead the original story w/Photo

    Friday Dec 19 | Seattle Post-Intelligencer

    ... Asia. ONO will have development and commercialization rights in those nations. Gilead took its first step into the cancer market this year with Zydelig, which won federal approval in July for three B-cell blood cancers: relapsed chronic lymphocytic ...

    Comment?

  16. Juno Joins Bespoke Cancer Treatment Frenzy as Questions LingerRead the original story

    Friday Dec 19 | The Washington Post

    It's a cancer therapy straight out of Greek mythology, bespoke medicine with astonishing results in the smallest and sickest of patients. The treatment, called a chimeric antigen receptor, or CAR for short, has captured the attention of the biggest drug companies and become a hotbed for biotechnology startups.

    Comment?

  17. Celgene Receives Positive CHMP Opinion to Extend REVLIMIDR...Read the original story

    Friday Dec 19 | ETaiwanNews.com

    ... in the revised European Public Assessment Report (EPAR). Multiple myeloma is a persistent and life-threatening blood cancer that is characterised by tumour proliferation and suppression of the immune system. 1 It is a rare but deadly disease: around ...

    Comment?

  18. GOP leader announces he'll undergo cancer treatmentRead the original story

    Friday Dec 19 | WAFF-TV Huntsville

    Republican Caucus Chairman Bill Ketron of Murfreesboro told media on Thursday that he has been diagnosed with non-Hodgkin's lymphoma. He said in a statement that the cancer was found last month after he discovered a lump in his neck.

    Comment?

  19. Juno Therapeuticsa stock surges in market debutRead the original story

    Friday Dec 19 | KDWN

    Juno genetically engineers a patient's own white blood cells to find and kill cancer cells in the body. It says its clinical trials have shown evidence of tumors shrinking.

    Comment?

  20. UPDATE 1-AstraZeneca's ovarian cancer drug gets U.S. approvalRead the original story

    Friday Dec 19 | Reuters

    AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission. An advisory panel to the U.S. Food and Drug Administration had voted in June against granting an accelerated approval to the drug, Lynparza, citing inadequate data.

    Comment?